Results from the Phase III SUNMO trial show that the Lunsumio and Polivy combination achieved statistically significant ...

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates ...

MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer ...

Roche and Genentech have announced outcomes from the randomised, multi-centre, international Phase III SUNMO trial for those ...

The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...

A suit cannot be maintained under the Civil law, merely based on an apprehension of litigation, without any concrete or ...

The decision to advance prasinezumab to Phase III was based on results from the Phase IIb PADOVA trial, which demonstrated ...

From June 23 to 29, leading dermatological skincare brand La Roche-Posay will host a skin-focused pop-up activation at Ikeja ...

Francisco Roche, a repeat felon, was sentenced to 110 months in prison for drug trafficking PCP and illegal firearm ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

The incident that took place at Washington State's Summer Con began after Alicia Hannah-Kim tapped the shoulder of the actor, ...